Accessibility Menu
MedX Health logo

MedX Health(OTC) MDXHF

Market Cap$14.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-66%
5 Year-56%
1 Year+5,275%
1 Month-2%
$0.04
+27.6%
+0.01Today
MedX Health last closing stock price
MetricPriceDate
Last closeUSD 0.042026-07-13
MedX Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+27.6%USD 0.032026-07-06
1 month-2.27%USD 0.042026-05-08
3 month-2.27%USD 0.042026-04-02
Year to date+290.91%USD 0.012025-12-18
1 year+5,275%USD 0.002025-05-16
3 year+2.38%USD 0.042023-06-23
5 year-55.65%USD 0.102021-07-14
Since inception-66.41%USD 0.132014-02-14

MedX Health Financials at a Glance

Market Cap

$14.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$540.27K

Net Income (TTM)

-CA$5.90M

EPS (TTM)

-$0.01

P/E Ratio

-3.16

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Price

$0.04

Volume

50

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Jun 1, 2026

MDXHF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedX Health

MedX Health Corp is a medical technology company focused on developing advanced diagnostic tools and therapeutic devices. The firm specializes in skin screening and light-based therapy solutions, catering to customers in Canada, the United States, and international markets.

Products and Services
  • SIAscopy technology for early detection of skin lesions
  • Imaging systems like SIAMETRICS and MoleMate for real-time assessments
  • Phototherapeutic devices for pain relief and tissue repair
Growth Outlook
  • Expansion of DermSecure telemedicine platform enhances accessibility
  • Increasing demand for non-invasive diagnostic tools in healthcare
  • Strategic partnerships may drive market penetration and revenue growth
Financial Highlights
  • Recent quarterly revenue of CAD 178,207 shows growth potential
  • Trailing twelve months (TTM) revenue of CAD 1,000,000 indicates market interest
  • Operating expenses reflect ongoing investment in R&D and marketing
MedX Health Corp is positioned in the medical devices industry, focusing on innovative solutions that address critical healthcare needs. The company's flagship product, SIAscopy, is designed for the early detection of skin cancer, a growing concern in dermatology. The integration of telemedicine through the DermSecure platform allows for remote diagnostics, making it easier for healthcare providers to access advanced tools. The growth outlook for MedX Health is promising, driven by the increasing demand for non-invasive diagnostic technologies and the potential for strategic partnerships that could enhance market reach. Recent financial data indicates a revenue increase, suggesting that the company is on a path toward greater market acceptance and operational efficiency. Investors may find MedX Health Corp an intriguing opportunity within the healthcare sector, particularly as the company continues to innovate and expand its product offerings. The focus on research and development, alongside a commitment to improving patient outcomes, positions MedX Health as a noteworthy player in the medical technology landscape.
AI Generated • Jul 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

John Gevisser

Website

www.medxhealth.com

Headquarters

Mississauga, ON L5T 1M2, CA

MDXHF Financials

Key Financial Metrics (TTM)

Gross Margin

-11.32%

Operating Margin

-738.95%

Net Income Margin

-1092.57%

Return on Equity

62.14%

Return on Capital

N/A

Return on Assets

-981.91%

Earnings Yield

-31.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

327.93M

Volume

50

Avg. Volume

3.95K

Financials (TTM)

Gross Profit

-CA$61.17K

Operating Income

-CA$3.99M

EBITDA

-CA$3.94M

Operating Cash Flow

-CA$4.04M

Capital Expenditure

-CA$2.10K

Free Cash Flow

-CA$4.04M

Cash & ST Invst.

CA$36.55K

Total Debt

CA$7.44M

MedX Health Performance Analysis

MedX Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 392,215-12.7%
20232023-12-31CAD 337,921-13.8%
20242024-12-31CAD 357,4545.8%
20252025-12-31CAD 338,703-5.2%
MedX Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-20.3%
Q32025-09-3052.8%
Q42025-12-312.2%
Q12026-03-3128.9%
MedX Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.02-8.9%
20232023-12-31CAD -0.02-19.5%
20242024-12-31CAD -0.01-42.2%
20252025-12-31CAD -0.0252.0%
MedX Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3023.7%
Q32025-09-304.4%
Q42025-12-31-46.5%
Q12026-03-3139.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$178.21K

+60.4%

Gross Profit

CA$51.64K

+8.3%

Gross Margin

28.98%

N/A

Market Cap

$14.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$45.20K

N/A

Employees

312

N/A

Net Income

-CA$1.23M

+23.2%

EBITDA

-CA$901.51K

+24.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$36.55K

+221.4%

Total Debt

CA$7.44M

-1.9%

Accounts Receivable

CA$98.66K

-70.6%

Inventory

CA$147.74K

-62.9%

Long Term Debt

CA$1.48M

+28.5%

Short Term Debt

CA$5.96M

-7.4%

Return on Assets

-9.82%

N/A

Return on Invested Capital

50.05%

N/A

Free Cash Flow

-CA$806.89K

-65.4%

Operating Cash Flow

-CA$806.89K

-65.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZIVOZIVO Bioscience, Inc.
$5.00+0.00%
PHYOFIXICO plc
$0.07+0.00%
CRRVFCVR Medical Corp.
$0.00+0.00%
PLNHPlanet 13 Holdings Inc.
$0.12-0.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%
TAT&T
$24.42+0.01%

Questions About MDXHF

What is the current price of MedX Health?

MedX Health is trading at $0.04 per share.

What is the 52-week range for MedX Health?

Over the past 52 weeks, MedX Health has traded between $0.00 and $0.05.

How much debt does MedX Health have?

As of the most recent reporting period, MedX Health reported total debt of CA$5.32M.

How much cash does MedX Health have on hand?

MedX Health reported CA$26.12K in cash and cash equivalents in its most recent financial results.

What is MedX Health’s dividend yield?

MedX Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services